Open-Label Study of the Safety and Efficacy of a Low Dose Oral Contraceptive Containing Norethindrone Acetate and Ethinyl Estradiol.
Phase of Trial: Phase III
Latest Information Update: 19 Apr 2013
At a glance
- Drugs Ethinylestradiol/norethisterone (Primary)
- Indications Pregnancy
- Focus Therapeutic Use
- Sponsors Warner Chilcott
- 11 Jun 2010 Actual patient number (1660) added as reported by ClinicalTrials.gov.
- 22 Oct 2008 Status changed from active, no longer recruiting to completed as reported by CT.gov
- 02 Jun 2008 New trial record.